American Journal of Ophthalmology
Volume 144, Issue 3 , Pages 390-395.e1 , September 2007

Photodynamic Therapy with Verteporfin for Corneal Neovascularization

  • Kyung-Chul Yoon

      Affiliations

    • Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Korea
    • Corresponding Author InformationInquiries to Kyung-Chul Yoon, Department of Ophthalmology, Chonnam National University Hospital, 8 Hak-Dong, Dong-Gu, Gwangju 501-757, Korea
    • ,
  • In-Cheon You

      Affiliations

    • Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Korea
    • ,
  • In-Seong Kang

      Affiliations

    • Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Korea
    • ,
  • Seong-Kyu Im

      Affiliations

    • Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Korea
    • ,
  • Jae-Kyoun Ahn

      Affiliations

    • Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Korea
    • ,
  • Yeoung-Geol Park

      Affiliations

    • Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Korea
    • ,
  • Kyu Youn Ahn

      Affiliations

    • Department of Anatomy, Chonnam National University Medical School and Hospital, Gwangju, Korea.

,Accepted 16 May 2007.

References 

  1. Chang JH, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Curr Opin Ophthalmol. 2001;12:242–249
  2. Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004;45:2666–2673
  3. Phillips K, Arffa R, Cintron C, et al. Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization. Arch Ophthalmol. 1983;101:640–643
  4. Joussen AM, Beecken WD, Moromizato Y, et al. Inhibition of inflammatory corneal amniogenesis by TNP-470. Invest Ophthalmol Vis Sci. 2001;42:2510–2516
  5. Abbas A, Khan B, Feroze AH, Hyman GF. Thalidomide prevents donor corneal graft neovascularization in an alkali burn model of corneal angiogenesis. J Pak Med Assoc. 2002;52:476–482
  6. Duenas Z, Torner L, Corbacho AM, et al. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules. Invest Ophthalmol Vis Sci. 1999;40:2498–2505
  7. Joussen AM, Kruse FE, Volcker HE, Kirchhof B. Topical application of methotrexate for inhibition of corneal angiogenesis. Graefes Arch Clin Exp Ophthalmol. 1999;237:920–927
  8. Ambati BK, Joussen AM, Ambati J, et al. Angiostatin inhibits and regresses corneal neovascularization. Arch Ophthalmol. 2002;120:1063–1068
  9. Wu PC, Liu CC, Chen CH, et al. Inhibition of experimental angiogenesis of cornea by somatostatin. Graefes Arch Clin Exp Ophthalmol. 2003;241:63–69
  10. Cursiefen C, Masli S, Ng TF, et al. Roles of thrombospondin-1 and –2 in regulating corneal and iris angiogenesis. Invest Ophthalmol Vis Sci. 2004;45:1117–1124
  11. Wu PC, Yang LC, Kuo HK, et al. Inhibition of corneal angiogenesis by local application of vasostatin. Mol Vis. 2005;11:28–35
  12. Sarayba MA, Li L, Tungsiripat T, et al. Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand. Exp Eye Res. 2005;80:435–442
  13. Kwon YS, Kim JC. Inhibition of corneal neovascularization by rapamycin. Exp Mol Med. 2006;38:173–179
  14. Yoon KC, Ahn KY, Lee JH, et al. Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model. Gene Ther. 2005;12:617–624
  15. Stechschulte S, Joussen A, von Recum H, et al. Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sci. 2001;42:1975–1979
  16. Ambati BK, Anand A, Joussen AM, et al. Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. Invest Ophthalmol Vis Sci. 2003;44:590–593
  17. Corrent G, Roussel TJ, Tseng SCG, Watson BD. Promotion of graft survival by photothrombotic occlusion of corneal neovascularization. Arch Ophthalmol. 1989;107:1501–1506
  18. Pillai CT, Dua HS, Hossain P. Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci. 2000;41:2148–2153
  19. Treatment of Age-related macular degeneration with Photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trial-TAP report. Arch Ophthalmol. 1999;117:1329–1345
  20. Blinder KJ, Bradley S, Bressler NM, et al. Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study group; Verteporfin in Photodynamic Therapy Study group (Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP Report no. 1). Am J Ophthalmol. 2003;136:407–418
  21. Blinder KJ, Blumenkranz MS, Bressler NM, et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial–VIP Report No. 3. Ophthalmology. 2003;110:667–673
  22. Holzer MP, Solomon KD, Vroman DT, et al. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:2954–2958
  23. Yoon KC, Ahn KY, Lee SE, et al. Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin. Curr Eye Res. 2006;31:215–224
  24. Brooks BJ, Ambati BK, Marcus DM, Ratanasit A. Photodynamic therapy for corneal neovascularization and lipid degeneration. Br J Ophthalmol. 2004;88:840
  25. Fossarello M, Peiretti E, Zucca I, Serra A. Photodynamic therapy of corneal neovascularization with verteporfin. Cornea. 2003;22:485–488
  26. Huang AJ, Watson BD, Hernandez E, Tseng SC. Photothrombosis of corneal neovascularization by intravenous rose Bengal and argon laser irradiation. Arch Ophthalmol. 1988;106:680–685
  27. Pallikaris IG, Tslimbaris MK, Iliaki OE, et al. Effectiveness of corneal neovascularization photothrombosis using phthalocyanine and a diode laser (675 nm). Lasers Surg Med. 1993;13:197–203
  28. Schmidt-Erfurth U, Hasan T, Schomacker K, et al. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg Med. 1995;17:178–188
  29. Primbs GB, Casey R, Wamser K, et al. Photodynamic therapy for corneal neovascularization. Ophthalmic Surg Lasers. 1998;29:832–838
  30. Gohto Y, Obana A, Kaneda K, Miki T. Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization. Exp Eye Res. 1998;67:313–322
  31. Sawa M, Awazu K, Takahashi T, et al. Application of femtosecond ultrashort pulse laser to photodynamic therapy mediated by indocyanine green. Br J Ophthalmol. 2004;88:826–831
  32. Ciulla TA, Criswell MH, Snyder WJ, Small W. Photodynamic therapy with PhotoPoint photosensitizer MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularization and rabbit choriocapillaris. Br J Ophthalmol. 2005;89:113–119
  33. Sheppard JD, Epstein RJ, Lattanzio FA, et al. Argon laser photodynamic therapy of human corneal vascularization after intravenous administration of dihematoporphyrin ether. Am J Ophthalmol. 2006;141:524–529
  34. Allison BA, Waterfield E, Richter AM, Levy JG. The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem Photobiol. 1991;54:709–715
  35. Maziere JC, Santus R, Morliere P, et al. Cellular uptake and photosensitizing properties of anti-cancer porphyrins in cell membranes and low and high density lipoproteins. J Photochem Photobiol B. 1990;6:61–68

PII: S0002-9394(07)00494-1

doi: 10.1016/j.ajo.2007.05.028

American Journal of Ophthalmology
Volume 144, Issue 3 , Pages 390-395.e1 , September 2007

Article Tools

* Image Usage & Resolution